在患有多发性骨髓瘤的患者中,B细胞成熟抗原仿制抗原受体-T疗法缓解了心力衰竭
Yunhong Wang1, Ke Zhang2, Xiaohui Suo3
1Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
ESC heart failure
|November 1, 2023
概括
针对B细胞成熟抗原 (BCMA) 的化学抗原受体 (CAR) -T细胞疗法对多发性骨髓瘤 (MM) 是有前途的. 这种疗法成功地治疗了由于轻链心脏粉症导致的严重心力衰竭的患者.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 心脏病学 心脏病学
背景情况:
- 多发性骨髓瘤 (MM) 患者与器官参与往往经历治疗结果不佳.
- 针对B细胞成熟抗原 (BCMA) 的化学抗原受体 (CAR) -T细胞疗法正在研究复发性/耐药性MM.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)